These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1596584

  • 21. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
    Van Mouwerik TJ, Pangallo CA, Willson JK, Fischer PH.
    Biochem Pharmacol; 1987 Mar 15; 36(6):809-14. PubMed ID: 3566784
    [Abstract] [Full Text] [Related]

  • 22. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR, Fryar-Tita EB, Zhou Y, Green S, Southerland WM, Bowen D.
    Anticancer Res; 2007 Mar 15; 27(6B):3791-9. PubMed ID: 18225534
    [Abstract] [Full Text] [Related]

  • 23. Potentiation of 5-fluorouracil cytotoxicity by combining hyperthermia and dipyridamole in vitro.
    Maehara Y, Sakaguchi Y, Kusumoto T, Kusumoto H, Sugimachi K.
    Anticancer Res; 1989 Mar 15; 9(4):967-9. PubMed ID: 2817823
    [Abstract] [Full Text] [Related]

  • 24. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
    Sobrero AF, Bertino JR.
    Int J Cell Cloning; 1986 Jan 15; 4(1):51-62. PubMed ID: 2936838
    [Abstract] [Full Text] [Related]

  • 25. Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy.
    Fryar EB, Das JR, Davis JH, Desoto JA, Laniyan I, Southerland WM, Bowen D.
    Anticancer Res; 2006 Jan 15; 26(3A):1861-7. PubMed ID: 16827118
    [Abstract] [Full Text] [Related]

  • 26. Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines.
    Smith PG, Marshman E, Calvert AH, Newell DR, Curtin NJ.
    Semin Oncol; 1999 Apr 15; 26(2 Suppl 6):63-7. PubMed ID: 10598557
    [Abstract] [Full Text] [Related]

  • 27. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
    Lönn U, Lönn S, Nylen U, Winblad G.
    Cancer Res; 1989 Mar 01; 49(5):1085-9. PubMed ID: 2521812
    [Abstract] [Full Text] [Related]

  • 28. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL, Fischer PH.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Comparison of in vitro assays for the cytotoxic effect of anticancer drugs].
    Li XT, Lin C, Li PY.
    Zhonghua Zhong Liu Za Zhi; 1986 May 01; 8(3):184-6. PubMed ID: 3743346
    [Abstract] [Full Text] [Related]

  • 33. Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexate.
    Das JR, Fryar EB, Epie NN, Southerland WM, Bowen D.
    Anticancer Res; 2006 May 01; 26(3A):1877-83. PubMed ID: 16827120
    [Abstract] [Full Text] [Related]

  • 34. [Biochemical modulation in cancer chemotherapy].
    Kawasaki H, Nobori T, Kamiya H, Sakurai M.
    Gan To Kagaku Ryoho; 1985 Apr 01; 12(4):815-29. PubMed ID: 3985645
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E, Zinn S, Boarman D, Allegra CJ.
    Cancer Res; 1990 Sep 15; 50(18):5834-40. PubMed ID: 1697502
    [Abstract] [Full Text] [Related]

  • 37. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
    Bhalla K, Birkhofer M, Grant S, Graham G.
    Exp Hematol; 1989 Jan 15; 17(1):17-20. PubMed ID: 2783247
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of thymidine transport by 3'-azido-3'-deoxythymidine and its metabolites.
    Zimmerman TP, Domin BA, Mahony WB.
    Oncol Res; 1993 Jan 15; 5(12):483-7. PubMed ID: 8086670
    [Abstract] [Full Text] [Related]

  • 39. Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks.
    Andreuccetti M, Allegrini G, Antonuzzo A, Malvaldi G, Conte PF, Danesi R, Del Tacca M, Falcone A.
    Eur J Cancer; 1996 Jun 15; 32A(7):1219-26. PubMed ID: 8758257
    [Abstract] [Full Text] [Related]

  • 40. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
    Rha SY, Izbicka E, Lawrence R, Davidson K, Sun D, Moyer MP, Roodman GD, Hurley L, Von Hoff D.
    Clin Cancer Res; 2000 Mar 15; 6(3):987-93. PubMed ID: 10741725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.